JAC Advance Access published online on September 30, 2003
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg439
© 2003 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original article
1 Dipartimento di Scienze Biomediche, sez. Microbiologia,
Università degli Studi di Trieste, Trieste, Italy
* Corresponding author. E-mail: banfi{at}dsbmail.units.it.
Received 30 July 2002
; revised 21 February 2003
; accepted 9 August 2003
A new rapid microdilution method, employing the dye
resazurin as an indicator of mycobacterial growth, was developed
to evaluate drug susceptibility of Mycobacterium tuberculosis reference
strain H37Rv and of 13 M. tuberculosis susceptible
or multidrug-resistant clinical strains. Different growth conditions
were evaluated. The MICs of isoniazid, rifampicin, streptomycin
and ethambutol were determined by the Microdilution Resazurin Assay
(MRA) and the results compared with those obtained by the agar proportion
method; complete agreement was always obtained. MRA resulted in
a rapid, reliable, simple and inexpensive coloured method suitable
for testing the susceptibility of M. tuberculosis clinical
strains to first-line drugs; its employment in evaluating new antibacterial
molecules is also suggested.
Keywords: M. tuberculosis, resazurin,
MIC evaluation, microdilution assay, first-line antitubercular drugs
Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Martin, F. Portaels, and J. C. Palomino Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis J. Antimicrob. Chemother., February 1, 2007; 59(2): 175 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Banfi, G. Scialino, D. Zampieri, M. G. Mamolo, L. Vio, M. Ferrone, M. Fermeglia, M. S. Paneni, and S. Pricl Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach J. Antimicrob. Chemother., July 1, 2006; 58(1): 76 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Coban, K. Bilgin, M. Uzun, N. T. Fisgin, A. Akgunes, C. C. Cihan, A. Birinci, and B. Durupinar Susceptibilities of Mycobacterium tuberculosis to Isoniazid and Rifampin on Blood Agar J. Clin. Microbiol., April 1, 2005; 43(4): 1930 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Montoro, D. Lemus, M. Echemendia, A. Martin, F. Portaels, and J. C. Palomino Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis J. Antimicrob. Chemother., April 1, 2005; 55(4): 500 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lemus, A. Martin, E. Montoro, F. Portaels, and J. C. Palomino Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis J. Antimicrob. Chemother., July 1, 2004; 54(1): 130 - 133. [Abstract] [Full Text] [PDF] |
||||

